Lymphadenopathy in the era of COVID-19 vaccination – an oncological dilemma in diagnostic imaging

Initial clinical experience with COVID-19 vaccination suggests that approved COVID-19 mRNA vaccines induce a strong immune response and thus cause a significantly higher incidence of axillary lymphadenopathy compared with other vaccines. It can therefore be expected to complicate the diagnosis of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Samkowski, Jakub, Sklinda, Katarzyna, Walecki, Jerzy Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288197/
https://www.ncbi.nlm.nih.gov/pubmed/35892070
http://dx.doi.org/10.5114/pjr.2022.117560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288197/
https://www.ncbi.nlm.nih.gov/pubmed/35892070
http://dx.doi.org/10.5114/pjr.2022.117560

Ejemplares similares